Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
Holders of 5% or more of HARP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Harpoon Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Harpoon Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Harpoon Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2022 | Logos Global Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | New Leaf Ventures III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Dec 27, 2021 | Logos Global Management LP | 13GOld format | – | New | – | SEC |
| Jul 16, 2021 | Arix Bioscience plc | 13D/AOld format | – | – | – | SEC |
| May 6, 2021 | MPM BioVentures 2014, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | MPM BioVentures 2014, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 12, 2021 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 20213:04 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20213:13 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Jan 12, 2021 | Arix Bioscience plc | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Harpoon Therapeutics, Inc. shares.
No Form 144 notices for Harpoon Therapeutics, Inc. are on file.